- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00520832
A Pilot Study Of The Effects Of Microcurrent On Three Sleep Surveys
Participants identified as having primary insomnia will be randomly assigned to groups receiving microcurrent stimulation or sham in a double-blind randomized controlled trial. The microcurrent device used is FDA approved for the treatment of insomnia.
The hypothesis is that the experimental group will have significantly improved scores on three sleep surveys after treatment while the sham group will not.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Missouri
-
Chesterfield, Missouri, United States, 63017
- Logan College of Chiropractic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Student, Faculty or Staff
- Age 18 - 40
- Symptoms of primary insomnia
Exclusion Criteria:
- No implanted electric devices
- No local infection, injury or malignancy
- No history of seizure or other neurological disorders
- No current use of prescription or other substances that could effect sleep quality or quantity
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: MC-E
20 minutes of sub-threshold microcurrent 2 hours before bedtime per day for 21 days.
|
20 minutes of sub-threshold microcurrent 2 hours before bedtime per day for 21 days.
Participants will receive a device identical to the active device used in the experimental condition, but which produces no current.
|
|
Placebo Comparator: MC-P
Participants will receive a device identical to the active device used in the experimental condition, but which produces no current.
|
20 minutes of sub-threshold microcurrent 2 hours before bedtime per day for 21 days.
Participants will receive a device identical to the active device used in the experimental condition, but which produces no current.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Pittsburgh Sleep Quality Index (PSQI)
|
|
Epworth Sleepiness Scale
|
|
Insomnia Severity Index
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Rodger Tepe, PhD, Logan College of Chiropractic
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SR0524070091
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.